Home » Topics » Regulatory » Patents

Patents
RSS

GlaxoSmithKline and collaborators identify NF-kappaB activators/HIV latency-reversing agents

June 18, 2020

Merck & Co. patents IDO-1 inhibitors

June 18, 2020

Novartis describes new PCSK9 inhibitors

June 18, 2020

New MALT1 inhibitors discovered at Takeda

June 18, 2020

Otsuka Pharmaceutical presents new antiseizure compounds

June 18, 2020

TOPADUR Pharma presents dual PDE5A inhibitors/soluble guanylate cyclase activators

June 17, 2020

3M Pharmaceuticals patents cytokine biosynthesis inducers

June 17, 2020

BioVersys synthesizes compounds interacting with accessory gene regulator A

June 17, 2020

New PCSK9 inhibitors discovered at Novartis

June 17, 2020

Pfizer describes new hemoglobin subunit beta polymerization inhibitors

June 17, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...